Medpace Holdings Inc
NASDAQ:MEDP

Watchlist Manager
Medpace Holdings Inc Logo
Medpace Holdings Inc
NASDAQ:MEDP
Watchlist
Price: 305.66 USD 3.12% Market Closed
Market Cap: 8.8B USD
Have any thoughts about
Medpace Holdings Inc?
Write Note

Intrinsic Value

The intrinsic value of one MEDP stock under the Base Case scenario is 286.89 USD. Compared to the current market price of 305.66 USD, Medpace Holdings Inc is Overvalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MEDP Intrinsic Value
286.89 USD
Overvaluation 6%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Medpace Holdings Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MEDP
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MEDP cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...

Fundamental Analysis

Medpace Holdings Inc
NASDAQ:MEDP
US
Life Sciences Tools & Services
Market Cap
9.1B USD
IPO
Aug 11, 2016
US
Life Sciences Tools & Services
Market Cap
9.1B USD
IPO
Aug 11, 2016
Price
$
$
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Medpace Holdings Inc

Provide an overview of the primary business activities
of Medpace Holdings Inc.

What unique competitive advantages
does Medpace Holdings Inc hold over its rivals?

What risks and challenges
does Medpace Holdings Inc face in the near future?

Has there been any significant insider trading activity
in Medpace Holdings Inc recently?

Summarize the latest earnings call
of Medpace Holdings Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medpace Holdings Inc.

Provide P/S
for Medpace Holdings Inc.

Provide P/E
for Medpace Holdings Inc.

Provide P/OCF
for Medpace Holdings Inc.

Provide P/FCFE
for Medpace Holdings Inc.

Provide P/B
for Medpace Holdings Inc.

Provide EV/S
for Medpace Holdings Inc.

Provide EV/GP
for Medpace Holdings Inc.

Provide EV/EBITDA
for Medpace Holdings Inc.

Provide EV/EBIT
for Medpace Holdings Inc.

Provide EV/OCF
for Medpace Holdings Inc.

Provide EV/FCFF
for Medpace Holdings Inc.

Provide EV/IC
for Medpace Holdings Inc.

Show me price targets
for Medpace Holdings Inc made by professional analysts.

What are the Revenue projections
for Medpace Holdings Inc?

How accurate were the past Revenue estimates
for Medpace Holdings Inc?

What are the Net Income projections
for Medpace Holdings Inc?

How accurate were the past Net Income estimates
for Medpace Holdings Inc?

What are the EPS projections
for Medpace Holdings Inc?

How accurate were the past EPS estimates
for Medpace Holdings Inc?

What are the EBIT projections
for Medpace Holdings Inc?

How accurate were the past EBIT estimates
for Medpace Holdings Inc?

Compare the revenue forecasts
for Medpace Holdings Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medpace Holdings Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medpace Holdings Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medpace Holdings Inc compared to its peers.

Compare the P/E ratios
of Medpace Holdings Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Medpace Holdings Inc with its peers.

Analyze the financial leverage
of Medpace Holdings Inc compared to its main competitors.

Show all profitability ratios
for Medpace Holdings Inc.

Provide ROE
for Medpace Holdings Inc.

Provide ROA
for Medpace Holdings Inc.

Provide ROIC
for Medpace Holdings Inc.

Provide ROCE
for Medpace Holdings Inc.

Provide Gross Margin
for Medpace Holdings Inc.

Provide Operating Margin
for Medpace Holdings Inc.

Provide Net Margin
for Medpace Holdings Inc.

Provide FCF Margin
for Medpace Holdings Inc.

Show all solvency ratios
for Medpace Holdings Inc.

Provide D/E Ratio
for Medpace Holdings Inc.

Provide D/A Ratio
for Medpace Holdings Inc.

Provide Interest Coverage Ratio
for Medpace Holdings Inc.

Provide Altman Z-Score Ratio
for Medpace Holdings Inc.

Provide Quick Ratio
for Medpace Holdings Inc.

Provide Current Ratio
for Medpace Holdings Inc.

Provide Cash Ratio
for Medpace Holdings Inc.

What is the historical Revenue growth
over the last 5 years for Medpace Holdings Inc?

What is the historical Net Income growth
over the last 5 years for Medpace Holdings Inc?

What is the current Free Cash Flow
of Medpace Holdings Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medpace Holdings Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medpace Holdings Inc

Current Assets 821.4m
Cash & Short-Term Investments 441.4m
Receivables 298.2m
Other Current Assets 81.8m
Non-Current Assets 1.1B
PP&E 258.2m
Intangibles 696.5m
Other Non-Current Assets 121.2m
Current Liabilities 1.1B
Accounts Payable 61.3m
Accrued Liabilities 286.1m
Other Current Liabilities 774.9m
Non-Current Liabilities 181.4m
Other Non-Current Liabilities 181.4m
Efficiency

Free Cash Flow Analysis
Medpace Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Medpace Holdings Inc

Revenue
2.2B USD
Cost of Revenue
-1.5B USD
Gross Profit
679.5m USD
Operating Expenses
-223.2m USD
Operating Income
456.3m USD
Other Expenses
-39.9m USD
Net Income
416.4m USD
Fundamental Scores

MEDP Profitability Score
Profitability Due Diligence

Medpace Holdings Inc's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Free Cash Flow
Exceptional ROE
Positive 3-Year Average ROIC
76/100
Profitability
Score

Medpace Holdings Inc's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

MEDP Solvency Score
Solvency Due Diligence

Medpace Holdings Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
65/100
Solvency
Score

Medpace Holdings Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MEDP Price Targets Summary
Medpace Holdings Inc

Wall Street analysts forecast MEDP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDP is 306.75 USD with a low forecast of 272.7 USD and a high forecast of 359.1 USD.

Lowest
Price Target
272.7 USD
11% Downside
Average
Price Target
306.75 USD
0% Upside
Highest
Price Target
359.1 USD
17% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Medpace Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MEDP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MEDP Insider Trading
Buy and sell transactions by insiders

MEDP News

Other Videos
What is the Intrinsic Value of one MEDP stock?

The intrinsic value of one MEDP stock under the Base Case scenario is 286.89 USD.

Is MEDP stock undervalued or overvalued?

Compared to the current market price of 305.66 USD, Medpace Holdings Inc is Overvalued by 6%.

Back to Top